Nano-Delivery in Pediatric Tumors: Looking Back, Moving Forward

Area of Science:

• Oncology
• Nanomedicine
• Pediatric Medicine

Background:

• Pediatric cancer survivors face long-term health issues due to current treatments.
• New therapeutic strategies are needed to target tumors while minimizing drug toxicity.
• Nanomedicine advancements offer potential solutions for improved pediatric cancer care.

Purpose of the Study:

• To review recent advances in nanodelivery systems for pediatric tumors.
• To highlight the potential of exosomes as therapeutic nanocarriers in pediatric oncology.
• To discuss applications in neuroblastoma, sarcomas, and brain tumors.

Main Methods:

• Literature review of nanomedicine applications in pediatric cancer treatment.
• Analysis of nanoformulations for targeted drug delivery and release.
• Exploration of exosome characteristics and their role in pediatric tumors.

Main Results:

• Nanocarriers enhance drug efficacy and reduce toxicity in pediatric cancer treatment.
• Exosomes demonstrate intrinsic targeting, stability, and biocompatibility for drug delivery.
• Clinical trials are ongoing for various nanodelivery systems in pediatric oncology.

Conclusions:

• Nanodelivery systems, particularly exosomes, represent a promising frontier in pediatric cancer therapy.
• Further research into exosomes could lead to novel diagnostic and therapeutic approaches for pediatric tumors.
• Targeted nanomedicine strategies are crucial for improving outcomes and quality of life for pediatric cancer survivors.